Literature DB >> 10549446

A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.

S R Zheng1, H M Zheng, S Z Qian, G W Sang, R F Kaper.   

Abstract

To compare the contraceptive efficacy, tolerability, and bleeding patterns, 200 healthy female volunteers received, in an open, comparative, randomized, multicenter study in China, either a single-rod (Implanon) or a six-capsule (Norplant) contraceptive implant for 2 years with an optional extension of up to 4 years. Women were exposed to Implanon for 341.6 woman-years and Norplant for 329.1 woman-years. There were no pregnancies during the study. Per 90-day reference period, the median number of bleeding/spotting days with Implanon decreased from 33.5 in the first period to 19.0-21.5 days in the last year. Similarly, with Norplant, the median number of bleeding/spotting days decreased from 34.5 to 18.0-23.0 days, respectively. The number of bleeding/spotting episodes during year 1 was 2.0 per 90-day reference period with Implanon and 3.0 per period with Norplant (p < 0.05 for periods 1-4). For the remaining 90-day periods, there was no statistical difference between the two groups. In general, there was less frequent bleeding with Implanon compared with Norplant, whereas the incidences of amenorrhea and infrequent bleeding were higher with Implanon than with Norplant. The mean overall incidence of prolonged bleeding fell markedly during the study, from 66.0% in reference period 1 to 27.3% in period 16 with Implanon and from 69.0% to 21.7% with Norplant, respectively. The most common adverse events were related to disturbed bleeding patterns, which were also the major reasons for discontinuation (Implanon n = 8; Norplant n = 14). Normal menses returned in almost all subjects within 3 months after removal of the implants. Implanon was inserted in a mean time of 0.61 min and Norplant in 3.90 min (p < 0.001). Similarly, the mean time required to remove the implant was significantly shorter for Implanon than for Norplant (2.18 min vs 11.25 min, p < 0.001). The maximum time required for removal of the implant was 10 min for the Implanon group and 60 min for the Norplant group. In both groups, blood pressure and hemoglobin were not affected, whereas body weight tended to increase. It can be concluded that both contraceptive systems demonstrated excellent contraceptive efficacy and were well tolerated. Compared with Norplant, there was less frequent bleeding with Implanon, whereas the incidence of infrequent bleeding and amenorrhea was higher. Implanon was significantly quicker to insert and to remove than was the multiple capsule system.

Entities:  

Keywords:  Asia; Bleeding; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Effectiveness; Contraceptive Implants; Contraceptive Methods; Contraceptive Removal; Developing Countries; Diseases; Eastern Asia; Family Planning; Levonorgestrel; Research Report; Signs And Symptoms; Treatment

Mesh:

Substances:

Year:  1999        PMID: 10549446     DOI: 10.1016/s0010-7824(99)00053-0

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

Review 1.  Recent developments in hormonal contraception.

Authors:  Eleanor A Drey; Philip D Darney
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

Review 2.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen-Mok; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 3.  Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.

Authors:  J Power; R French; F Cowan
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

4.  Long-acting progestin-only contraceptives enhance human endometrial stromal cell expressed neuronal pentraxin-1 and reactive oxygen species to promote endothelial cell apoptosis.

Authors:  O Guzeloglu-Kayisli; M Basar; J P Shapiro; N Semerci; J S Huang; F Schatz; C J Lockwood; U A Kayisli
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

5.  Association of short-term bleeding and cramping patterns with long-acting reversible contraceptive method satisfaction.

Authors:  Justin T Diedrich; Sanyukta Desai; Qiuhong Zhao; Gina Secura; Tessa Madden; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2014-07-18       Impact factor: 8.661

Review 6.  Progestin-only contraceptives: effects on weight.

Authors:  Laureen M Lopez; Alison Edelman; Mario Chen; Conrad Otterness; James Trussell; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2013-07-02

Review 7.  Contraceptive failure in the United States.

Authors:  James Trussell
Journal:  Contraception       Date:  2011-03-12       Impact factor: 3.375

Review 8.  Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.

Authors:  Irving Sivin
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

9.  Examining the efficacy, safety, and patient acceptability of the etonogestrel implantable contraceptive.

Authors:  Heather Hohmann
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

Review 10.  Safety and Benefits of Contraceptives Implants: A Systematic Review.

Authors:  Morena Luigia Rocca; Anna Rita Palumbo; Federica Visconti; Costantino Di Carlo
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.